Cargando…

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV

Mostrar otras versiones (1)

SARS-CoV-2, a novel coronavirus (CoV) that causes COVID-19, has recently emerged causing an ongoing outbreak of viral pneumonia around the world. While distinct from SARS-CoV, both group 2B CoVs share similar genome organization, origins to bat CoVs, and an arsenal of immune antagonists. In this rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lokugamage, Kumari G., Hage, Adam, de Vries, Maren, Valero-Jimenez, Ana M., Schindewolf, Craig, Dittmann, Meike, Rajsbaum, Ricardo, Menachery, Vineet D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2020
Materias:	Virus-Cell Interactions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654262/ https://www.ncbi.nlm.nih.gov/pubmed/32938761 http://dx.doi.org/10.1128/JVI.01410-20

Ejemplares similares

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog
por: Chen, Jiyao, et al.
Publicado: (2022)

SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation
por: Hörnich, Bojan F., et al.
Publicado: (2021)

SARS-CoV-2 NSP12 Protein Is Not an Interferon-β Antagonist
por: Li, Aixin, et al.
Publicado: (2021)

Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
por: Essalmani, Rachid, et al.
Publicado: (2022)

Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
por: Chiem, Kevin, et al.
Publicado: (2021)

SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2021)

Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection
por: Ariumi, Yasuo
Publicado: (2022)

The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication
por: Nilsson-Payant, Benjamin E., et al.
Publicado: (2021)

Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells
por: Aicher, Sophie-Marie, et al.
Publicado: (2022)

Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load
por: Rajagopala, Seesandra V., et al.
Publicado: (2023)

Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin
por: Qian, Yisong, et al.
Publicado: (2021)

Spike Glycoprotein and Host Cell Determinants of SARS-CoV-2 Entry and Cytopathic Effects
por: Nguyen, Hanh T., et al.
Publicado: (2021)

The “LLQY” Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles
por: Du, Shouwen, et al.
Publicado: (2022)

Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2
por: Zhao, Xuesen, et al.
Publicado: (2020)

Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1
por: Geng, Qibin, et al.
Publicado: (2022)

All Domains of SARS-CoV-2 nsp1 Determine Translational Shutoff and Cytotoxicity of the Protein
por: Frolov, Ilya, et al.
Publicado: (2023)

LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2
por: Zhao, Xuesen, et al.
Publicado: (2020)

SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells
por: Nchioua, Rayhane, et al.
Publicado: (2022)

Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants
por: Su, Chao, et al.
Publicado: (2022)

Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets
por: Belser, Jessica A., et al.
Publicado: (2022)

Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry
por: Sengar, Anjali, et al.
Publicado: (2023)

SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA
por: Li, Aixin, et al.
Publicado: (2023)

Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19
por: Undi, Ram Babu, et al.
Publicado: (2022)

Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions
por: Zhang, Lizhou, et al.
Publicado: (2023)

The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication
por: Li, Jie, et al.
Publicado: (2023)

Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Muruato, Antonio, et al.
Publicado: (2021)

Evasion of Type I Interferon by SARS-CoV-2
por: Xia, Hongjie, et al.
Publicado: (2020)

Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition
por: Navaratnarajah, Chanakha K., et al.
Publicado: (2021)

A Versatile Reporter System To Monitor Virus-Infected Cells and Its Application to Dengue Virus and SARS-CoV-2
por: Pahmeier, Felix, et al.
Publicado: (2021)

Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry
por: Choi, Sheyne S. A., et al.
Publicado: (2022)

Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells
por: Miura, Koya, et al.
Publicado: (2023)

Identification of host dependency factors involved in SARS-CoV-2 replication organelle formation through proteomics and ultrastructural analysis
por: Pahmeier, Felix, et al.
Publicado: (2023)

Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2
por: Wang, Xinxin, et al.
Publicado: (2023)

SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption
por: Alruwaili, Muhannad, et al.
Publicado: (2023)

An Infectious cDNA Clone of SARS-CoV-2
por: Xie, Xuping, et al.
Publicado: (2020)

SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig
por: Li, Yujun, et al.
Publicado: (2020)

Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
por: Kreutzberger, Alex J. B., et al.
Publicado: (2021)

Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories
por: Malicoat, Johnny, et al.
Publicado: (2022)

Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling
por: Frolova, Elena I., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4n4qh6u1os4toqje1oa8g66krp